Multiple targets involved in collagen synthesis modulation—such as MMP, LAIR-1, DDR1, HSP47, and LARP6—have been identified [29, 128, 129] sparking interest in collagen’s untapped potential in cancer immunotherapy. The gene discussed is DDR1; the disease is cancer.